These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38838741)

  • 1. Development of a Behavior-Change Intervention toward Benzodiazepine Deprescribing in Older Adults Living in Nursing Homes.
    Evrard P; Henrard S; Spinewine A
    J Am Med Dir Assoc; 2024 Aug; 25(8):105053. PubMed ID: 38838741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study.
    Evrard P; Henrard S; Foulon V; Spinewine A
    J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement.
    Heinrich CH; McHugh S; McCarthy S; Curran GM; Donovan MD
    Res Social Adm Pharm; 2023 Aug; 19(8):1202-1213. PubMed ID: 37230873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers and enablers towards benzodiazepine-receptor agonists deprescribing in nursing homes: A qualitative study of stakeholder groups.
    Evrard P; Damiaens A; Patey AM; Grimshaw JM; Spinewine A
    Explor Res Clin Soc Pharm; 2023 Mar; 9():100258. PubMed ID: 37124470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deprescribing benzodiazepine receptor agonists in older adults: a mixed-methods study to adapt the Canadian D-PRESCRIBE intervention to the Belgian community setting.
    Pétein C; Dujardin N; de Montigny M; Dewez E; Spinewine A; Henrard S
    BMJ Open; 2024 Aug; 14(8):e085396. PubMed ID: 39153767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an intervention to facilitate implementation and uptake of diabetic retinopathy screening.
    Riordan F; Racine E; Phillip ET; Bradley C; Lorencatto F; Murphy M; Murphy A; Browne J; Smith SM; Kearney PM; McHugh SM
    Implement Sci; 2020 May; 15(1):34. PubMed ID: 32429983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the content and delivery of an intervention to Change AdhereNce to treatment in BonchiEctasis (CAN-BE): a qualitative approach incorporating the Theoretical Domains Framework, behavioural change techniques and stakeholder expert panels.
    McCullough AR; Ryan C; O'Neill B; Bradley JM; Elborn JS; Hughes CM
    BMC Health Serv Res; 2015 Aug; 15():342. PubMed ID: 26297038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying behavior change techniques for inclusion in a complex intervention targeting antipsychotic prescribing to nursing home residents with dementia.
    Walsh KA; Timmons S; Byrne S; Browne J; Mc Sharry J
    Transl Behav Med; 2021 Mar; 11(2):470-483. PubMed ID: 32589204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a complex community pharmacy intervention package using theory-based behaviour change techniques to improve older adults' medication adherence.
    Patton DE; Ryan C; Hughes CM
    BMC Health Serv Res; 2020 May; 20(1):418. PubMed ID: 32404090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-design of a behaviour change intervention to equip geriatricians and pharmacists to proactively deprescribe medicines that are no longer needed or are risky to continue in hospital.
    Scott S; Atkins B; Kellar I; Taylor J; Keevil V; Alldred DP; Murphy K; Patel M; Witham MD; Wright D; Bhattacharya D
    Res Social Adm Pharm; 2023 May; 19(5):707-716. PubMed ID: 36841632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Barriers and enablers for deprescribing benzodiazepine receptor agonists in older adults: a systematic review of qualitative and quantitative studies using the theoretical domains framework.
    Evrard P; Pétein C; Beuscart JB; Spinewine A
    Implement Sci; 2022 Jul; 17(1):41. PubMed ID: 35804428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
    Mena S; Moullin JC; Schneider M; Niquille A
    BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deprescribing in nursing homes: Protocol for nested, randomised controlled hybrid trials of deprescribing interventions.
    Cateau D; Ballabeni P; Mena S; Bugnon O; Niquille A
    Res Social Adm Pharm; 2021 Apr; 17(4):786-794. PubMed ID: 32622774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spread and scale of an electronic deprescribing software to improve health outcomes of older adults living in nursing homes: study protocol for a stepped wedge cluster randomized trial.
    Nadeau ME; Henry JL; Lee TC; Bortolussi-Courval É; Goodine C; McDonald EG
    Trials; 2021 Nov; 22(1):763. PubMed ID: 34727956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deprescribing research in nursing home residents using routinely collected healthcare data: a conceptual framework.
    Thorpe C; Niznik J; Li A
    BMC Geriatr; 2023 Aug; 23(1):469. PubMed ID: 37542226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an intervention to improve appropriate polypharmacy in older people in primary care using a theory-based method.
    Cadogan CA; Ryan C; Francis JJ; Gormley GJ; Passmore P; Kerse N; Hughes CM
    BMC Health Serv Res; 2016 Nov; 16(1):661. PubMed ID: 27852287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs.
    Bai I; Isenor JE; Reeve E; Whelan AM; Martin-Misener R; Burgess S; Kennie-Kaulbach N
    Res Social Adm Pharm; 2022 Aug; 18(8):3350-3357. PubMed ID: 34895842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practitioner behaviour change intervention for deprescribing in the hospital setting.
    Scott S; May H; Patel M; Wright DJ; Bhattacharya D
    Age Ageing; 2021 Feb; 50(2):581-586. PubMed ID: 32875321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.